{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:11:47Z","timestamp":1787857907317,"version":"build-2784847793"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2020.552421","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:56:24Z","timestamp":1605182184000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":92,"title":["Risk of Cardiovascular and Cerebrovascular Events in Polycystic Ovarian Syndrome Women: A Meta-Analysis of Cohort Studies"],"prefix":"10.3389","volume":"7","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2265.1992.tb02296.x","article-title":"How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?","volume":"37","author":"Clayton","year":"1992","journal-title":"Clin Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/humrep\/15.4.785","article-title":"Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome","volume":"15","author":"Cibula","year":"2000","journal-title":"Hum Reprod."},{"key":"B4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000181560","article-title":"Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS)","volume":"33","author":"Kinoshita","year":"1990","journal-title":"Horm Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/jwh.2017.6584","article-title":"Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study","volume":"27","author":"Bedaiwy","year":"2018","journal-title":"J Women's Health."},{"key":"B6","unstructured":"Cardiovascular Diseases2019"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14656566.2019.1701655","volume":"21","author":"Vatopoulou","year":"2020","journal-title":"Management of obesity in adolescents with polycystic ovary syndrome. Expert Opin Pharmacother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2019.1698026","article-title":"Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics","volume":"36","author":"Jiang","year":"2019","journal-title":"Gynecol Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"33715","DOI":"10.18632\/oncotarget.9553","article-title":"Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"B10","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/09513590.2017.1347779","article-title":"Association between polycystic ovary syndrome and the risk of stroke and all-cause mortality: insights from a meta-analysis","volume":"33","author":"Zhou","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e3054","DOI":"10.1002\/dmrr.3054","article-title":"Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies","volume":"34","author":"Jacewicz-Swiecka","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"R. E. A.-S. P. C. W. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jrsm.1047","article-title":"Semiparametric hazard function estimation in meta-analysis for time to event data","volume":"3","author":"Wang","year":"2012","journal-title":"Res Synth Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/sim.1188","article-title":"Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes","volume":"21","author":"Deeks","year":"2002","journal-title":"Stat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/oxfordjournals.aje.a114593","article-title":"Interpretation and choice of effect measures in epidemiologic analyses","volume":"125","author":"Greenland","year":"1987","journal-title":"Am J Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1002\/(sici)1097-0258(19991030)18:20<2693::aid-sim235>3.0.co;2-v","article-title":"Explaining heterogeneity in meta-analysis: a comparison of methods","volume":"18","author":"Thompson","year":"1999","journal-title":"Stat Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/biostatistics\/1.3.247","article-title":"Meta-analysis, funnel plots and sensitivity analysis","volume":"1","author":"Copas","year":"2000","journal-title":"Biostatistics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1161\/ATVBAHA.114.304136","article-title":"Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study","volume":"34","author":"Calderon-Margalit","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/00016349209006227","article-title":"Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women","volume":"71","author":"Dahlgren","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.18632\/oncotarget.23985","article-title":"Coronary artery disease risk in young women with polycystic ovary syndrome","volume":"9","author":"Ding","year":"2018","journal-title":"Oncotarget"},{"key":"B21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1530\/EJE-14-1108","article-title":"Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome","volume":"172","author":"Glintborg","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","first-page":"74","article-title":"Risk of cardiovascular events in patients with polycystic ovary syndrome","volume":"70","author":"Iftikhar","year":"2012","journal-title":"Neth J Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/09513590701705189","article-title":"Polycystic ovary syndrome: a follow-up study on diabetes mellitus, cardiovascular disease and malignancy 15\u201325 years after ovarian wedge resection","volume":"23","author":"Lunde","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/cen.12068","article-title":"Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study","volume":"78","author":"Mani","year":"2013","journal-title":"Clin Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1089\/jwh.2015.5441","article-title":"Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome","volume":"25","author":"Merz","year":"2016","journal-title":"J Women's Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the rotterdam study","volume":"103","author":"Meun","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1210\/jc.2012-1690","article-title":"Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study","volume":"97","author":"Morgan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health\u2014National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"49109","DOI":"10.1155\/2007\/49109","article-title":"The genetic basis of the polycystic ovary syndrome: a literature review including discussion of PPAR-gamma","volume":"2007","author":"Unluturk","year":"2007","journal-title":"PPAR Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.1210\/jc.2009-0839","article-title":"Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age","volume":"94","author":"Alsamarai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1210\/jc.2010-2959","article-title":"Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/1570161116666180828154006","article-title":"Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome","volume":"17","author":"Armeni","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"B40","first-page":"247","article-title":"Responses of endothelial cells towards ischemic conditioning following acute myocardial infarction","volume":"1","author":"Hern\u00e1ndez-Res\u00e9ndiz","year":"2018","journal-title":"Cond Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"key":"B42","first-page":"697","article-title":"Current perspectives in polycystic ovary syndrome","volume":"68","author":"Richardson","year":"2003","journal-title":"Am Fam Physician"},{"key":"B43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10815-017-1047-7","article-title":"Polycystic ovary syndrome throughout a woman's life","volume":"35","author":"Bellver","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.bbrc.2005.05.046","article-title":"Synergic action of insulin and genistein on Na+\/K+\/2Cl- cotransporter in renal epithelium","volume":"332","author":"Ueda-Nishimura","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"B46","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: current perspectives","volume":"7","author":"Palomba","year":"2015","journal-title":"Int J Women's Health"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.552421\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T11:56:30Z","timestamp":1605182190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2020.552421\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":46,"alternative-id":["10.3389\/fcvm.2020.552421"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2020.552421","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,12]]},"article-number":"552421"}}